Table 4.
Initial model | Final model | ||||||
---|---|---|---|---|---|---|---|
Explanatory variable | OR | 95% CI | p value | Explanatory variable | OR | 95% CI | p value |
Sex (reference: Male) | |||||||
Female | .72 | .39–1.34 | .295 | ||||
Age | 1.00 | .97–1.02 | .703 | ||||
Race (reference: Caucasian) | Race (reference: Caucasian) | ||||||
Asian | 1.41 | .61–3.27 | .420 | Asian | 1.50 | .66–3.42 | .337 |
African American | 3.88 | 1.76–8.53 | .001* | African American | 3.54 | 1.66–7.58 | .001* |
Other | 2.18 | .87–5.44 | .097 | Other | 2.20 | .89–5.45 | .087 |
Ethnicity (reference: Not Hispanic) | |||||||
Hispanic | .37 | .13–1.10 | .074 | Hispanic | .35 | .12–1.04 | .059 |
Payer (reference: Commercial) | Payer (reference: Commercial) | ||||||
Medi-Cal | 2.21 | 1.13–4.33 | .021* | Medi-Cal | 2.19 | 1.12–4.27 | .022* |
Medicare | 1.43 | .59–3.50 | .428 | Medicare | 1.38 | .68–2.78 | .371 |
CCI score | 1.01 | .76–1.32 | .974 | ||||
Depression | 3.17 | 1.75–5.75 | .000* | Depression | 3.15 | 1.77–5.61 | < .001* |
Diabetes | 1.91 | .82–4.47 | .134 | Diabetes | 1.97 | .97–4.00 | .062 |
Kidney disease | 2.25 | .93–5.44 | .073 | Kidney disease | 2.66 | 1.17–6.08 | .020* |
MI | 1.67 | .21–13.13 | .629 | ||||
COPD | 1.92 | .98–3.77 | .057 | COPD | 1.92 | 1.25–1.93 | .039* |
Liver disease | 1.39 | .55–3.51 | .492 | ||||
Constant | .11 | .001* | Constant | .07 | < .001* |
OR: odds ratio; CI: confidence interval; CCI: Charlson comorbidity index; MI: myocardial infarction; COPD, chronic obstructive pulmonary disease
*p < .05